News Daily News FDA Approves Triple Therapy Polypill for High Blood Pressure Michael O'Riordan June 10, 2025
News Daily News Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD Michael O'Riordan March 06, 2025
News Daily News Coverage and Use of Impella and Watchman: A Tale of Four Countries Michael O'Riordan March 04, 2025
News Opinion Off Script Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term Wayne Batchelor, MD, MHS, MBA February 07, 2025
News Daily News IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication L.A. McKeown December 03, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News Medical Devices Cleared on Faulty Predicates More Likely to be Recalled Michael O'Riordan January 17, 2023
News Conference News ESC 2022 Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms Yael L. Maxwell August 31, 2022
News Daily News Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection L.A. McKeown August 23, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Daily News Robert M. Califf Becomes 25th Commissioner of the US FDA L.A. McKeown February 15, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News TCTMD’s Top 10 Most Popular Stories for December 2021 Caitlin E. Cox December 29, 2021
News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021
News Daily News Papers Probe Temporal Link Between COVID-19 Vaccines and Myocarditis Michael O'Riordan June 17, 2021